Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinical demographics

From: The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma

Patient Age Gender Diagnosis Catheter(s) tip placement area
1 49 M Glioblastoma Non-contrast and contrast enhancing
2 68 M Glioblastoma Non-contrast enhancing
3 32 M Glioblastoma Non-contrast and contrast enhancing
4 60 M Glioblastoma Non-contrast enhancing
5 51 M Glioblastoma Non-contrast enhancing
6 70 F Glioblastoma Non-contrast enhancing
  1. All patients diagnosed with recurrent glioblastoma and catheter tips were placed in non-contrast enhancing tumor. In patients 1 and 3, tips were also placed in contrast enhancing tissue